Received Apr 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 7NX57 | — |
Underdose; immunization to an adult; This non-serious case was reported by a other health professional via call center representative and described the occurrence of underdose in a 77-year-old female patient who received HBV (Engerix B 10 mcg) (batch number 7NX57, expiry date 12-DEC-2026) for prophylaxis. On 11-APR-2025, the patient received Engerix B 10 mcg. On 11-APR-2025, an unknown time after receiving Engerix B 10 mcg, the patient experienced underdose (Verbatim: Underdose) and adult use of a child product (Verbatim: immunization to an adult). The outcome of the underdose and adult use of a child product were not applicable. Additional Information: GSK Receipt Date: 11-APR-2025 The reporter reported that gave a hepatitis b pediatrics immunization to an adult and they like to know the recommendations which led to Adult use of a child product and underdose. The Vaccine Administration Facility is the same as Primary Reporter.